Nothing Special   »   [go: up one dir, main page]

EP1773388A4 - Vaccins contre le sras et procedes de production d'anticorps tres puissants - Google Patents

Vaccins contre le sras et procedes de production d'anticorps tres puissants

Info

Publication number
EP1773388A4
EP1773388A4 EP05786720A EP05786720A EP1773388A4 EP 1773388 A4 EP1773388 A4 EP 1773388A4 EP 05786720 A EP05786720 A EP 05786720A EP 05786720 A EP05786720 A EP 05786720A EP 1773388 A4 EP1773388 A4 EP 1773388A4
Authority
EP
European Patent Office
Prior art keywords
production
active antibodies
sars vaccines
sars
vaccines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05786720A
Other languages
German (de)
English (en)
Other versions
EP1773388A2 (fr
Inventor
Shibo Jiang
Yuxian He
Shuwen Liu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
New York Blood Center Inc
Original Assignee
New York Blood Center Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by New York Blood Center Inc filed Critical New York Blood Center Inc
Publication of EP1773388A2 publication Critical patent/EP1773388A2/fr
Publication of EP1773388A4 publication Critical patent/EP1773388A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP05786720A 2004-06-02 2005-06-01 Vaccins contre le sras et procedes de production d'anticorps tres puissants Withdrawn EP1773388A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US57611804P 2004-06-02 2004-06-02
US14192505A 2005-05-31 2005-05-31
PCT/US2005/019266 WO2005120565A2 (fr) 2004-06-02 2005-06-01 Vaccins contre le sras et procedes de production d'anticorps tres puissants

Publications (2)

Publication Number Publication Date
EP1773388A2 EP1773388A2 (fr) 2007-04-18
EP1773388A4 true EP1773388A4 (fr) 2008-08-20

Family

ID=35503665

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05786720A Withdrawn EP1773388A4 (fr) 2004-06-02 2005-06-01 Vaccins contre le sras et procedes de production d'anticorps tres puissants

Country Status (4)

Country Link
EP (1) EP1773388A4 (fr)
AU (1) AU2005251738A1 (fr)
CA (1) CA2569142A1 (fr)
WO (1) WO2005120565A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115190911B (zh) * 2020-02-10 2024-04-23 港大科桥有限公司 对sars冠状病毒2具有免疫原性的组合物、其制备方法和用途
PH12022552164A1 (en) * 2020-02-19 2023-11-29 United Biomedical Inc Designer peptides and proteins for the detection, prevention and treatment of coronavirus disease, 2019 (covid-19)
CN113321715B (zh) * 2020-02-28 2023-02-17 北京万泰生物药业股份有限公司 新型冠状病毒抗原及其检测用途
US11857620B2 (en) 2020-03-11 2024-01-02 Immunitybio, Inc. Method of inducing immunity against SARS-CoV-2 using spike (s) and nucleocapsid (N)-ETSD immunogens delivered by a replication-defective adenovirus
US20210284716A1 (en) 2020-03-11 2021-09-16 Immunitybio, Inc. ACE2-Fc Trap
WO2021195089A1 (fr) * 2020-03-23 2021-09-30 Sorrento Therapeutics, Inc. Protéines de fusion de l'antigène fc-coronavirus et acides nucléiques, vecteurs, compositions et procédés d'utilisation associés
CN111983226A (zh) 2020-03-25 2020-11-24 新加坡国立大学 SARSr-CoV抗体的检测
CN113461828B (zh) * 2020-03-30 2023-10-27 北京科兴中维生物技术有限公司 针对2019-nCoV的重组蛋白疫苗及其制备方法
CN111574622A (zh) * 2020-04-07 2020-08-25 刘会芳 一种抗人新型冠状病毒肺炎的抗体及其制备方法
CN113527444B (zh) * 2020-04-13 2022-12-27 中国科学院微生物研究所 与新型冠状病毒的抗体有效结合的表位
CN115485375A (zh) * 2020-05-11 2022-12-16 莱桑多公司 Ace-2受体的可溶性受体片段的病毒中和作用
CN111574623A (zh) * 2020-05-25 2020-08-25 西安咸辅生物科技有限责任公司 一种新冠病毒s1+s2抗独特型卵黄抗体疫苗的制备方法
WO2021237516A1 (fr) * 2020-05-27 2021-12-02 上海济煜医药科技有限公司 Anticorps anti-sars-cov-2 et son utilisation
CN113230395B (zh) * 2020-05-29 2022-07-19 中国科学院微生物研究所 一种β冠状病毒抗原、β冠状病毒二联疫苗及其制备方法和应用
EP3925971A1 (fr) * 2020-06-16 2021-12-22 Viravaxx AG Procédé d'identification de composés pouvant influencer la liaison au récepteur de virus
CN113797326B (zh) * 2020-06-17 2024-01-19 上海君实生物医药科技股份有限公司 一种预防冠状病毒引起疾病的疫苗
WO2022018528A1 (fr) * 2020-07-19 2022-01-27 Immunitybio, Inc. Dosage d'anticorps des muqueuses pour la covid-19
CN111808199A (zh) * 2020-07-27 2020-10-23 西安咸辅生物科技有限责任公司 一种ace2抗独特型卵黄抗体疫苗的制备方法
CN114057845A (zh) * 2020-08-07 2022-02-18 清华大学 一种预防新型冠状病毒肺炎covid-19的多肽、免疫原性偶联物及其用途
CN112225814A (zh) * 2020-09-29 2021-01-15 东莞博盛生物科技有限公司 一种新型冠状病毒rbd融合蛋白亚单位疫苗及其制备方法和应用
CN112480268B (zh) * 2020-12-10 2021-08-03 北京康乐卫士生物技术股份有限公司 一种新型冠状病毒的重组亚单位疫苗及其应用
CN116333161B (zh) * 2021-02-04 2024-01-26 广东克冠达医药科技有限公司 一种covid-19亚单位疫苗及其制备方法与应用
GB2606693A (en) * 2021-04-08 2022-11-23 Exosis Inc Fusion protein
CN113583137B (zh) * 2021-06-15 2022-08-05 北京康乐卫士生物技术股份有限公司 一种新型冠状病毒南非突变株的重组亚单位疫苗及其应用
WO2023125976A1 (fr) * 2021-12-31 2023-07-06 广州国家实验室 Vaccin à base de protéines de fusion

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
BISHT HIMANI ET AL: "Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 101, no. 17, 27 April 2004 (2004-04-27), pages 6641 - 6646, XP002391528, ISSN: 0027-8424 *
BONAVIA A ET AL: "Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 77, no. 4, February 2003 (2003-02-01), pages 2530 - 2538, XP002342003, ISSN: 0022-538X *
HE Y ET AL: "Receptor-binding domain of SARS-CoV spike protein induces highly potent neutralizing antibodies: implication for developing subunit vaccine", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS INC. ORLANDO, FL, US, vol. 324, no. 2, 12 November 2004 (2004-11-12), pages 773 - 781, XP004599673, ISSN: 0006-291X *
LI WENHUI ET AL: "Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 426, no. 6965, 27 November 2003 (2003-11-27), pages 450 - 454, XP002342002, ISSN: 0028-0836 *
SUI JIANHUA ET AL: "Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 101, no. 8, 24 February 2004 (2004-02-24), pages 2536 - 2541, XP002332534, ISSN: 0027-8424 *
WONG SWEE KEE ET AL: "A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 279, no. 5, 30 January 2004 (2004-01-30), pages 3197 - 3201, XP002332535, ISSN: 0021-9258 *
YANG ZHI-YONG ET AL: "A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice", NATURE, NATURE PUBLISHING GROUP, LONDON, GB, vol. 428, no. 6982, 1 April 2004 (2004-04-01), pages 561 - 564, XP002304794, ISSN: 0028-0836 *

Also Published As

Publication number Publication date
CA2569142A1 (fr) 2005-12-22
EP1773388A2 (fr) 2007-04-18
AU2005251738A1 (en) 2005-12-22
WO2005120565A8 (fr) 2006-02-09
WO2005120565A3 (fr) 2007-05-18
WO2005120565A2 (fr) 2005-12-22

Similar Documents

Publication Publication Date Title
EP1773388A4 (fr) Vaccins contre le sras et procedes de production d'anticorps tres puissants
EP1737574A4 (fr) Materiau fonctionnel et nouveaux procedes permettant de fabriquer des dispositifs microfluidiques
DE602005009866D1 (de) Verfahren zur herstellung von n-phenylpyrazol-1-carboxamiden
DE602005018601D1 (de) Verfahren zur herstellung von 2-aminothiazol-5-aro
ATE516816T1 (de) Verfahren zur herstellung von impfstoffen
DE602005016292D1 (de) Verfahren zur herstellung von glatiramer
DE502005002059D1 (de) Verfahren zur herstellung von polyetheralkoholen
EP1917101A4 (fr) Procede de fabrication et de revetement de composants nanostructures
EP2057268A4 (fr) Vaccin à adn servant à traiter l'hépatite b chronique, et son procédé de préparation
EP1947705A4 (fr) Dispositif émetteur de lumière et son procédé de fabrication
DE602004027955D1 (de) vERFAHREN ZUR HERSTELLUNG VON DEHNBAREN UND STRECKBAREN LAMINATEN
EP1870457A4 (fr) Cristal de dipeptide et son procédé de production
ATE427040T1 (de) Verfahren zur herstellung von nahrungsmitteln und so hergestelltes nahrungsmittel
ATA8002004A (de) Verfahren zur herstellung von 2-butanol
EP1907468A4 (fr) Procede de preparation de nanocomposites, et nanocomposites
EP1848843A4 (fr) Procédé de fabrication de lingots de silicium à solidification directionnelle
DE502005007762D1 (de) Verfahren zur herstellung von zahnrädern
ATE461919T1 (de) Verfahren zur herstellung von montelukast und zwischenprodukte dafür
DE502007004242D1 (de) DNS-Konstrukt und Verfahren zur fermentativen Herstellung von Fusionsproteinen
DE602005016095D1 (de) Verfahren zur herstellung von hochreinem teicoplanin
ATE488508T1 (de) Verfahren zur herstellung von irbesartan und zwischenprodukte davon
ATE406372T1 (de) Verfahren zur herstellung von 3-o-geschützten morphinonen und 3-o-geschützten morphinondienolcarboxylaten
ATE476403T1 (de) Verfahren zur herstellung und aufreinigung von n- propylbromid
DE102005032999A8 (de) Sensor und Verfahren zur Herstellung desselben
DE602006008976D1 (de) Verfahren zur herstellung von carboxaniliden

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070101

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LIU, SHUWEN

Inventor name: HE, YUXIAN

Inventor name: JIANG, SHIBO

R17D Deferred search report published (corrected)

Effective date: 20070518

RIC1 Information provided on ipc code assigned before grant

Ipc: C07K 1/00 20060101ALI20070724BHEP

Ipc: A61K 39/215 20060101AFI20070724BHEP

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20080717

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20090123